Y-Biologics, Inc. (KOSDAQ:338840)
South Korea · Delayed Price · Currency is KRW 9,330.00
0.00 (0.00%)
At close: Jul 27, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 132.46 billion as of July 28, 2026. Its market cap has decreased by -24.33% in one year.
Market Cap
132.46B
Enterprise Value
106.92B
Revenue
2.79B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,330.00
ChartMarket Cap Chart
Since December 5, 2023, Y-Biologics's market cap has decreased from 177.50B to 132.46B, a decrease of -25.37%. That is a compound annual growth rate of -10.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 132.46B | -61.89% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
| Dec 5, 2023 | 177.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| curacle co.,ltd. | 184.07B |
| Genome & Company | 171.97B |
| Kanaph Therapeutics | 165.89B |
| Bio Solution | 164.63B |
| NIBEC | 160.29B |
| Ensol Biosciences | 150.63B |
| Prestige Biologics | 139.80B |
| ISU Abxis | 125.59B |